今天分享的是：电商运营：家清日化场景消费研究白皮书 报告共计：43页 《电商运营：家清日化场景消费研究白皮书》显示，中国家清日化市场规模从2015年的347.7亿元增长至2024年的583.9亿元，预计2028年超700亿元，线上渠 道占比逐年提升，2024年淘宝天猫家居清洁销售额同比增17.5%。市场呈现品质化、功能细分、绿色环保及场景细分趋势：消费者追求高效精细清洁工具 （如内衣洗衣液、厨房专用清洁剂）和高品质家居饰品，71%关注成分安全与环保，推动行业向天然成分、低碳包装转型，春夏季驱蚊、洗衣场景专用产品 需求突出。 消费者需求多元，基础清洁外，更注重护肤功能、便捷高效及情感共鸣，年轻群体偏好时尚品牌，中老年侧重性价比，女性关注护肤美妆类，男性对功能性 产品需求高。购买决策依赖社交媒体口碑，电商渠道因丰富性和便利性占比上升，但传统零售仍具不可替代性，线下门店通过打造家清专区提升体验。 品牌格局中，蓝月亮等头部品牌凭借专业形象和全渠道布局巩固地位，新锐品牌如UPO元本生活、芝芙莲通过线上营销和差异化产品快速崛起，牛大哥等专 业品牌聚焦职业清洁市场。未来，市场竞争将更激烈，产品创新聚焦香氛情绪价值、天然成分 ...

拟6亿投建研发生产基地 润本股份于2023年10月上市，主要从事个人护理类、驱蚊类产品的研发、生产和销售，目前已形成婴童护理产 品、驱蚊产品、精油产品三大核心产品系列。 5月6日晚间，润本股份发布的公告显示，公司拟在广州市黄埔区中新广州知识城国际生物医药创新园投建新的产 研基地(投资标的名称：润本生物技术研发生产基地项目)，持续巩固公司的C2M供应链壁垒，满足未来持续增长 的产销研需求。 公告显示，上述项目投资金额为6亿元，建设内容主要包含办公区、研发区、生活区、生产制造区、园区配套工 程，用于开展个护用品、化妆品、医疗器械、医药制造行业相关产品的研发、生产制造及其配套服务。 实际上，在中新广州知识城国际生物医药创新园，润本股份已重金投入生产项目。 2024年，润本股份率先竞得位于中新广州知识城国际生物医药创新园，凤亨一路以北，凤亨二路以南，康联三路 以西ZSCB-E3-3地块，面积约3.2953万平方米的国有建设用地使用权，并于当年9月审议通过《关于签署投入产出 监管协议暨对外投资的议案》，同意公司以自有或自筹资金投资7亿元建设"润本智能智造未来工厂项目"。 在业绩持续提升之时，润本股份（603193）(6 ...

润本股份 20250506 摘要 在品类方面，我们对运动护理给予较高的测试预期，目标为 30%到 40%的增 长；驱蚊产品按照往年的正常增速目标设定为 20%到 25%；精油类产品更新 • 山姆渠道从 3 月初开始上架，3 月份销售收入约为 1,200 万元，4 月份超 过 2000 万元，已达到当前阶段性的收入预期，净利率约为 28%，基本没 有投放费用。 • 公司通过组合销售日常护肤品与防晒产品提升单品销量，新面霜和洗护类 产品未来可能会继续提价，产品品类结构变化对售价影响显著，整体客单 价从原来的 30 元左右提升至接近 40 元。 预期较低，大概是 10%到 15%。核心品类仍然是护理和驱蚊。在渠道方面， 本地渠道预计有 50%到 60%的增长；天猫渠道大概 15%；京东约 20%；飞 亚达经销商则保持在 40%左右。 润本股份在 2024 年取得了超预期的成绩，请问主要做了哪些工作？ 2024 年我们在新品和渠道两方面进行了重点投入。在新品方面，我们推出了 室内电热蚊香液加定时功能，以及户外便携装驱蚊喷雾，这两个产品销售情况 良好。在渠道方面，我们首次在抖音平台重点推广驱蚊产品，并取得了市占率 第一 ...

[Table_Title] 证券研究报告 / 公司点评报告 产品渠道齐发力，业绩持续高增 报告摘要： [Table_Summary] 事件： 润本股份发布 2024 年报及 2025 年一季报，2024 年公司实现营收 13.18 亿元/+27.61%，归母净利润 3.00 亿元/+32.80%，扣非归母净利润 2.89 亿元/+32.28%，非经常性损益 0.11 亿元，主要来自政府补助和公允价 值变动损益。2024Q4 公司实现营收 2.81 亿元/+34.01%，归母净利润 0.39 亿元/-13.28%，扣非归母净利润 0.33 亿元/-19.57%。拟每 10 股派 发现金红利 2.30 元（含税）。2025Q1 实现营收 2.40 亿元/+44.00%，归 母净利润 0.44 亿元/+24.60%，扣非归母净利润 0.39 亿元/+ 22.85%。 点评： 多产品多渠道全面推进，收入维持快增。2024 年公司实现营收 13.18 亿元/+27.61%，分产品看：1）驱蚊产品营收 4.39 亿元/占比 33.33%/ +35.39%，其中销量+25.89%。2）婴童护理产品营收 6.90 亿元/占比 ...

Core Insights - The company achieved robust growth in 2024 and Q1 2025, with revenue increasing by 28% and net profit by 33% in 2024, and Q1 2025 revenue up by 44% and net profit by 25% [1][2] Financial Performance - In 2024, the company reported revenue of 1.318 billion yuan, a year-on-year increase of 27.61%, and a net profit of 300 million yuan, up 32.8% [2] - Q4 2024 revenue was 281 million yuan, a 34.01% increase year-on-year, while net profit decreased by 13.28% [2] - Q1 2025 revenue reached 240 million yuan, a 44% increase year-on-year, with net profit at 44 million yuan, up 24.6% [2] Product Category Performance - In 2024, the core product categories showed strong growth, with mosquito repellent revenue at 439 million yuan (up 35.39%) and baby care revenue at 690 million yuan (up 32.42%) [3] - In Q1 2025, baby care revenue surged by 65.57% to 179 million yuan, while mosquito repellent revenue increased by 10.5% [3] Profitability and Cost Structure - The overall gross margin for 2024 was 58.17%, an increase of 1.82 percentage points, with a net profit margin of 22.77% [4] - In Q1 2025, the gross margin was 57.67%, with a net profit margin of 18.41%, reflecting a decrease of 2.87 percentage points [4] Future Outlook - The company is expected to continue its growth trajectory, with projected net profits of 389 million yuan, 481 million yuan, and 583 million yuan for 2025, 2026, and 2027, respectively, representing year-on-year growth rates of 30%, 24%, and 21% [1][4]

Core Viewpoints - The A-share market experienced a collective adjustment, with the Shanghai Composite Index falling by 0.2% to 3288.41 points, the Shenzhen Component Index down by 0.62%, and the ChiNext Index down by 0.65% [1][6] - The total transaction volume in the Shanghai and Shenzhen markets was 1.06 trillion yuan, with the banking and steel sectors leading gains, while real estate, social services, and automotive sectors lagged [1][6] - The report highlights the government's upcoming measures to stabilize employment and promote high-quality economic development, including support for enterprises to maintain employment and enhance vocational training [7] Market Performance - As of the end of Q1 2025, the total scale of the wealth management market reached 29.14 trillion yuan, reflecting a year-on-year growth of 9.41% [13][16] - The report indicates that the risk appetite in the wealth management sector remains low, with fixed-income products dominating the market [14][16] - The performance of various fund types showed mixed results, with QDII funds leading with a return of 3.93% [9][10] Company-Specific Insights - The report on Runben Co., Ltd. indicates a significant revenue increase of 27.61% year-on-year, reaching 1.318 billion yuan in 2024, with a net profit growth of 32.80% [17][18] - The company launched over 90 new products in 2024, focusing on mosquito repellent and baby care products, which contributed to its revenue growth [19][20] - The report on Wuliangye shows a revenue of 89.175 billion yuan in 2024, with a year-on-year growth of 7.09%, and a net profit of 31.853 billion yuan, reflecting a growth of 5.44% [23][24] Investment Recommendations - The report suggests that the technology, pharmaceutical, and consumer sectors are receiving high attention from funds, with significant allocations towards electronic and food & beverage industries [8][10] - The investment outlook for Runben Co., Ltd. remains positive, with expected EPS for 2025 adjusted to 0.93 yuan per share, maintaining a "buy" rating [20] - Wuliangye's investment value is highlighted due to its strong brand and increased dividend payout ratio, with a projected net profit growth of 5.50% for 2025 [26]

Investment Rating - The investment rating for the company is "Buy" (maintained) with a target price of —— yuan over the next 6 months [1]. Core Insights - The company continues to experience high revenue growth, with a diversified product matrix [2]. - The revenue for 2024 is projected to be 13.2 billion yuan, representing a year-on-year growth of 27.6%, while the net profit attributable to the parent company is expected to reach 3.0 billion yuan, up 32.8% year-on-year [9]. - The company has a strong focus on the baby care and mosquito repellent segments, which are expected to show good growth potential [9][10]. Financial Performance Summary - Revenue and Profit Forecast: - 2024A: Revenue of 13.18 billion yuan, net profit of 3.00 billion yuan - 2025E: Revenue of 17.72 billion yuan, net profit of 3.92 billion yuan - 2026E: Revenue of 22.99 billion yuan, net profit of 5.05 billion yuan - 2027E: Revenue of 28.79 billion yuan, net profit of 6.36 billion yuan - Growth Rates: - Revenue growth rates are projected at 27.61% for 2024, 34.39% for 2025, 29.77% for 2026, and 25.22% for 2027 - Net profit growth rates are expected to be 32.80% for 2024, 30.52% for 2025, 28.78% for 2026, and 26.05% for 2027 [4][11]. Product and Market Analysis - The company has successfully increased the average selling price of its baby care products, with significant room for further price increases compared to competitors [9]. - The product matrix has been continuously enriched, with over 90 new or upgraded products launched in 2024, including children's sunscreen and egg yolk oil series [9]. - Online sales channels have shown rapid growth, with significant contributions from platforms like Douyin, while offline channels are also expanding [9]. Profitability Metrics - The overall gross margin for 2024 is projected at 58.2%, with a net profit margin of 22.8% [9]. - The company is expected to maintain a healthy return on equity (ROE), projected to be 14.43% in 2024, increasing to 19.19% by 2027 [4][11].

智通财经记者 | 朱咏玲 智通财经编辑 | 许悦 靠儿童驱蚊产品起家的广州日化企业润本股份日前公布2024年度业绩，公司营收同比增长27.61%至 13.18亿元，归母净利润增长32.80%至3.00亿元。 这是润本股份自2020年以来连续五年实现盈利双增，营收从不足5亿元发展至如今规模。润本股份能实 现快速增长，很大程度上在于它切中了儿童驱蚊这个相对空白的利基市场，在小品类上做出了大生意。 这个策略能帮助企业较快地在市场上站稳脚跟，但只聚焦细分赛道意味着天花板有限，企业发展到一定 阶段后，长期的成长性会受到考验。 润本股份的应对策略是开拓品类，在驱蚊产品之外拓展了婴童护理和精油系列两大产品系列，这些系列 都属于"润本"单一品牌之下。 从2022年起，婴童护理已经成为润本股份营收贡献最大的系列。2024年，婴童护理系列对总营收占比 52.4%，超过了驱蚊系列的33.3%和精油系列的12.0%。 且婴童护理系列实现了量价齐升，润本股份近些年推出了单价更高的新品来上探价格带，例如2025年上 线的防晒产品。2025年第一季度，该系列产品的平均售价为9.65元，而2024年第一季度为7.19元。对比 更早之前，20 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [2] Core Views - The company reported a revenue of 1.32 billion yuan in 2024, representing a year-on-year increase of 27.6%, and a net profit attributable to shareholders of 300 million yuan, up 32.8% year-on-year [5] - The company is expected to maintain strong growth in the baby care segment and continue to launch new products to capture market share [8] Company Overview - Latest closing price: 35.58 yuan - Total shares: 4.05 billion, circulating shares: 1.03 billion - Total market capitalization: 14.4 billion yuan, circulating market capitalization: 3.7 billion yuan - 52-week high/low: 36.53/16.13 yuan - Debt-to-asset ratio: 6.3% - Price-to-earnings ratio: 48.08 [4] Financial Performance - In Q4 2024, the company achieved revenue and net profit of 280 million yuan and 40 million yuan, respectively, with year-on-year growth of 34% and a decline of 13% [5] - In Q1 2025, revenue and net profit were 240 million yuan and 44 million yuan, respectively, with year-on-year growth of 44% and 25% [5] - The gross profit margin for 2024 increased by 1.8 percentage points to 58.2% [7] - The company expects net profits of 390 million yuan, 500 million yuan, and 604 million yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 36 times, 29 times, and 24 times [8][11] Revenue Breakdown - In 2024, revenue from mosquito repellent, baby care, and essential oils was 440 million yuan, 690 million yuan, and 160 million yuan, respectively, with year-on-year growth of 35%, 32%, and 8% [6] - For Q1 2025, the revenue growth rates for mosquito repellent, baby care, and essential oils were 66%, 11%, and -6%, respectively [6] - Online direct sales and non-platform distributors showed strong performance, with revenue growth of 24.8% and 39.6% in 2024 [6]

Investment Rating - The investment rating for the company is "Buy" and is maintained [2] Core Views - The company reported a revenue of 1.32 billion yuan in 2024, representing a year-on-year increase of 27.6%, and a net profit attributable to shareholders of 300 million yuan, up 32.8% year-on-year [5] - The company is expected to maintain strong growth in the baby care segment and continue launching new products to capture market share [8] Company Overview - Latest closing price: 35.58 yuan - Total shares: 4.05 billion, circulating shares: 1.03 billion - Total market capitalization: 14.4 billion yuan, circulating market capitalization: 3.7 billion yuan - 52-week high/low: 36.53/16.13 yuan - Debt-to-asset ratio: 6.3% - Price-to-earnings ratio: 48.08 [4] Financial Performance - In Q4 2024, the company achieved revenue and net profit of 280 million yuan and 40 million yuan, respectively, with year-on-year growth of 34% and a decline of 13% [5] - In Q1 2025, revenue and net profit were 240 million yuan and 44 million yuan, respectively, with year-on-year growth of 44% and 25% [5] - The gross profit margin for 2024 increased by 1.8 percentage points to 58.2% [7] - The company expects net profits of 390 million yuan, 500 million yuan, and 604 million yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 36 times, 29 times, and 24 times [8][11] Revenue Breakdown - In 2024, revenue from mosquito repellent, baby care, and essential oils was 440 million yuan, 690 million yuan, and 160 million yuan, respectively, with year-on-year growth of 35%, 32%, and 8% [6] - For Q1 2025, revenue growth rates for mosquito repellent, baby care, and essential oils were 66%, 11%, and -6%, respectively [6] - Online direct sales and non-platform distributors showed strong performance, with revenue growth of 24.8% and 39.6% in 2024 [6]